Featured Research

from universities, journals, and other organizations

Unraveling misfolded molecules using 'reprogrammed' yeast protein could lead to new brain disease therapies

Date:
January 16, 2014
Source:
Perelman School of Medicine at the University of Pennsylvania
Summary:
At the heart of brain diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease is protein misfolding. At present, there is no known way to reverse protein misfolding. But researchers have found a possible way to unravel misfolded proteins by "reprogramming" a common yeast protein.

Alpha-synuclein forms Lewy Body-like inclusions in the cytoplasm of yeast (left), but these are dissolved and alpha-synuclein returns to the plasma membrane upon expression of an engineered Hsp104 variant.
Credit: James Shorter, Ph.D., Perelman School of Medicine, University of Pennsylvania; Cell

At the heart of brain diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and Parkinson's disease is protein misfolding, in which distorted proteins are unable to perform their normal functions. At present, there is no known way to reverse protein misfolding.

Related Articles


But James Shorter, Ph.D., associate professor of Biochemistry and Biophysics, at the Perelman School of Medicine, University of Pennsylvania, has found a possible way to unravel misfolded proteins by "reprogramming" Hsp104, a common yeast protein. The work was published this week in Cell.

Hsp104 is a "chaperone" protein, one that assists in the proper formation and functioning of other protein complexes. Although Hsp104 is one of the most common proteins on the planet, it has no analogue in humans or animals.

"We don't understand why animals have lost the gene for Hsp104, but at the same time, we've been wondering: 'Is there a therapeutic opportunity in this?'" asks Shorter. "Can we add it back as a disruptive technology to antagonize the protein misfolding that characterizes some diseases?"

In previous studies, Shorter's lab established that the natural version of Hsp104 is active against neurodegenerative proteins such as alpha-synuclein. "We expressed the wild-type protein in a rat model of Parkinson's disease and observed beneficial phenotypes," explains Shorter. "But the wild-type protein just doesn't work as well as we would like."

In the present study, the team screened large libraries of Hsp104 variants to find versions that could both maintain protein structure and break up misfolded clumps. "Luckily several variants came out of our screen that could suppress the toxicity associated with misfolded and clumped FUS, TDP-43, and alpha-synuclein disease proteins in yeast, while also enhancing proper protein function," he adds.

Shorter's team collaborated with the lab of Guy Caldwell at the University of Alabama to test Hsp104 variants in the worm C. elegans and found marked rescue of alpha-synuclein toxicity, the first time that engineered enzymes have been shown to suppress neurodegeneration in a multicellular animal.

"This is very exciting, as there are no agents that are known to rescue neurodegeneration and at the same time reverse protein misfolding," notes first author Meredith Jackrel, Ph.D., a postdoctoral fellow in the Shorter lab. "Certainly nobody's ever tried to reprogram an existing protein to try to accomplish that task."

Shorter identified Hsp104's coiled-coil middle domain as a major area affecting its ability to function as a chaperone, noting that minor mutations in this domain appear to have wide-ranging potential to unlock the molecule's protein clump-busting capabilities. He suggests that the middle domain of Hsp104 functions much like an electrical capacitor, storing the protein's beneficial possibilities. A seemingly small tweak of the middle-domain structure, as well as other parts of the molecule such as the pore loops, can unleash a surprising therapeutic power.

With that power now demonstrated in the relatively primitive worm species, the team's next step will be to move to a more complex animal model in mice, where the side effects of introducing a foreign protein into an organism might be a concern.

Shorter explains that aside from Hsp104's declumping function, "the other major goal from a bioengineering viewpoint is to make the tweaked Hsp104 specific in what it targets because all the variants we have at the moment seem to work across the board. That's not what you want for a therapeutic, because there might be off-target effects."

He stresses that although his protein reengineering approach is not yet a cure or practical treatment for neurodegenerative disease, it's a major first step toward that ultimate goal and shows that clump busting -- what was previously thought impossible -- is within reach, adding, "We've defined that it is possible to achieve clot-busting activity in a simple model system. The challenge is to move it forward from there."


Story Source:

The above story is based on materials provided by Perelman School of Medicine at the University of Pennsylvania. Note: Materials may be edited for content and length.


Journal Reference:

  1. MeredithE. Jackrel, MorganE. DeSantis, BryanA. Martinez, LauraM. Castellano, RachelM. Stewart, KimA. Caldwell, GuyA. Caldwell, James Shorter. Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events. Cell, 2014; 156 (1-2): 170 DOI: 10.1016/j.cell.2013.11.047

Cite This Page:

Perelman School of Medicine at the University of Pennsylvania. "Unraveling misfolded molecules using 'reprogrammed' yeast protein could lead to new brain disease therapies." ScienceDaily. ScienceDaily, 16 January 2014. <www.sciencedaily.com/releases/2014/01/140116130441.htm>.
Perelman School of Medicine at the University of Pennsylvania. (2014, January 16). Unraveling misfolded molecules using 'reprogrammed' yeast protein could lead to new brain disease therapies. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2014/01/140116130441.htm
Perelman School of Medicine at the University of Pennsylvania. "Unraveling misfolded molecules using 'reprogrammed' yeast protein could lead to new brain disease therapies." ScienceDaily. www.sciencedaily.com/releases/2014/01/140116130441.htm (accessed October 31, 2014).

Share This



More Plants & Animals News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How A Chorus Led Scientists To A New Frog Species

How A Chorus Led Scientists To A New Frog Species

Newsy (Oct. 30, 2014) A frog noticed by a conservationist on New York's Staten Island has been confirmed as a new species after extensive study and genetic testing. Video provided by Newsy
Powered by NewsLook.com
Surfer Accidentally Stands on Shark, Gets Bitten

Surfer Accidentally Stands on Shark, Gets Bitten

AP (Oct. 30, 2014) A 20-year-old competition surfer said on Thursday he accidentally stepped on a shark's head before it bit him off the Australian east coast. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Ebola Inflicts Heavy Toll on Guinean Potato Trade

Ebola Inflicts Heavy Toll on Guinean Potato Trade

AFP (Oct. 30, 2014) The Ebola epidemic has seen Senegal and Guinea Bissau close its borders with Guinea and the economic consequences have started to be felt, especially in Fouta Djallon, where the renowned potato industry has been hit hard. Duration: 02:01 Video provided by AFP
Powered by NewsLook.com
Genetically Altered Glowing Flower on Display in Tokyo

Genetically Altered Glowing Flower on Display in Tokyo

Reuters - Innovations Video Online (Oct. 30, 2014) Just in time for Halloween, a glowing flower goes on display in Tokyo. Instead of sorcery and magic, its creators used science to genetically modify the flower, adding a naturally fluorescent plankton protein to its genetic mix. Ben Gruber reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins